Insulet Corporation Stock News

Investors with an interest in Medical - Products stocks have likely encountered both EssilorLuxottica Unsponsored ADR (ESLOY) and Insulet (PODD). But which of these two companies is the best option fo

Insulet Corporation aims to continue to revolutionize the diabetes market. The company has seen strong commercial traction, driven by the Omnipod 5, although operating leverage is still hard to come b

Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.

Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Insulet (PODD). But which of these two stocks presents investors with the better value opport

Stocks such as Franklin Electric (FELE), Insulet (PODD) & Wingstop (WING) have striking earnings growth and positive estimate revisions.

PODD stock hit new highs in March when it joined the S&P 500. Now, shares are breaking out.

Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.

Insulet (PODD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.40 per share a year ago.

We have narrowed our search to five stocks that are set to report earnings results this week. These are: PODD, BKNG, BILL, JCI and COLD.

MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.

Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Health care services and health-related stocks continue to show strength in the market. The post Option Trading: Insulet Butterfly Taps Into Stock's Leadership, Potential Rally appeared first on Inves

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

After Insulet jumped on news it was joining the S&P 500, PODD stock is wound up for a breakout with earnings due. The post Insulet Joins S&P 500 And Gets Ready To Pump Up New Breakout With 56% Growth

BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.